Advertisement

Topics

Impax Laboratories, Inc. Company Profile

21:32 EDT 23rd September 2017 | BioPortfolio

Impax Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally, where strategically appropriate, Impax has developed marketing partnerships to fully leverage its technology platform. Impax Laboratories is headquartered in Hayward, California, and has a full range of capabilities in its Hayward, Philadelphia and Taiwan facilities. For more information, please visit the Company's Web site at: www.impaxlabs.com.

Location

30831 Huntwood Avenue
Hayward
California
94544
United States of America

Contact

Phone: (510) 476-2000
Fax: 510) 471-3200
Email: info@impaxlabs.com


News Articles [384 Associated News Articles listed on BioPortfolio]

Zacks: Brokerages Anticipate Impax Laboratories Inc (IPXL) Will...

Wall Street analysts forecast that Impax Laboratories Inc will post $196.18 million in sales for the current fiscal quarter, Zacks reports. Four analysts have made estimates for Impax Laboratories'...

Analyzing Impax Laboratories

Pfizer and Impax Laboratories are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional owner...

$0.14 EPS Expected for Impax Laboratories, Inc. (IPXL) This Quarter

Analysts expect Impax Laboratories, Inc. to report earnings per share of $0.14 for the current fiscal quarter, according to Zacks . Four analysts have provided estimates for Impax Laboratories' ea...

Zacks: Analysts Anticipate Impax Laboratories Inc (IPXL) to Announce $0.13 EPS

Equities analysts expect that Impax Laboratories Inc will post earnings per share of $0.13 for the current quarter, according to Zacks Investment Research . Four analysts have made estimates for Impax...

Morning Stock Stories: Impax Laboratories, Inc.

With a market cap of 1.21B, Impax Laboratories, Inc. has a large market cap size. Impax Laboratories, Inc. has been on the stock market since its IPO date on the 12/19/1995.

Here's Why Impax Laboratories Inc Jumped 18% In July

In response to receiving a double dose of good news from the Food and Drug Administration and some bullish commentary from Wall Street, shares of Impax Laboratories , a maker of generic and branded ph...

Impax Laboratories, Inc. (IPXL) Stock Price Up -3.8%

Shares of Impax Laboratories, Inc. rose 3.8% during mid-day trading on Friday . The company traded as high as $25.70 and last traded at $22.90.

Impax Laboratories in Talks to Merge With Amneal Pharmaceuticals

Impax Laboratories Inc. is in talks to combine with rival Amneal Pharmaceuticals LLC as the companies seek to build strength in a challenging market for generic-drug makers. Impax and closely held Amn...

PubMed Articles [188 Associated PubMed Articles listed on BioPortfolio]

Project management: importance for diagnostic laboratories.

The constraints applied on diagnostic laboratories to improve both quality and productivity together with personal shortages incite laboratory managers to constantly optimize the laboratory workflows,...

Cancer incidence in female laboratory employees: extended follow-up of a Swedish cohort study.

Work in chemical laboratories is associated with exposure to chemicals, of which some are known or suspected carcinogens. A cohort study of laboratory workers in Stockholm followed until 1992 showed a...

This Is not Participatory Design - A Critical Analysis of Eight Living Laboratories.

Design of Health Technology for elderly and care personnel has a high priority because of a severe increase of elderly citizens in need of health care combined with a decrease of resources in the heal...

Consistency of BRCA1 and BRCA2 Variant Classifications Among Clinical Diagnostic Laboratories.

Genetic tests of the cancer predisposition genes BRCA1 and BRCA2 inform significant clinical decisions for both physicians and patients. Most uncovered variants are benign, and determining which few a...

CLSI-Based Validation of Manufacturer-Derived Reference Intervals on the Cobas 8000 Platform.

Reference intervals provided by diagnostic test manufacturers should be transferred to clinical laboratories after validation. Although protocols exist, laboratories rarely perform and report on resul...

Clinical Trials [231 Associated Clinical Trials listed on BioPortfolio]

A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal

The objectives of this study are to compare the efficacy and safety of Clotrimazole troche/ lozenges USP, 10 mg (Unique Pharmaceutical Laboratories, India) vs. Clotrimazole Troche/ Lozenge...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fed condi...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr. Reddy's Laboratories Limited, Finasteride Tablets 1 mg Under Fasting Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fasting c...

Companies [933 Associated Companies listed on BioPortfolio]

Impax Laboratories, Inc. and Perrigo Company

Impax Laboratories, Inc. (“Impax”) is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the developm...

Impax Laboratories, Inc.

Impax Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-re...

Impax Laboratories Incorporated

The December 1999 merger of IMPAX Pharmaceuticals, Inc. and Global Pharmaceutical Corporation formed a new organization named IMPAX Laboratories, Inc. The mission for IMPAX Laboratories is to become a...

Impax Pharmaceuticals

KENT LABORATORIES

Since 1974 KENT LABORATORIES has been a specialist in the production of polyclonal antibodies, radial immunodiffusion kits and conjugated immunoglobulin fractions for manufacturers, universities and l...

More Information about "Impax Laboratories, Inc." on BioPortfolio

We have published hundreds of Impax Laboratories, Inc. news stories on BioPortfolio along with dozens of Impax Laboratories, Inc. Clinical Trials and PubMed Articles about Impax Laboratories, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Impax Laboratories, Inc. Companies in our database. You can also find out about relevant Impax Laboratories, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...


Corporate Database Quicklinks



Searches Linking to this Company Record